MedTrace Logo

Supreme LMA Use in Urgent Caesarean Section

NCT02026882 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 584

Last updated 2020-08-03

No results posted yet for this study

Summary

The Supreme Laryngeal Mask Airway (SLMA) is a single use supraglottic device that provides a good seal for positive pressure ventilation and good first attempt insertion rate of 98% in low risk patients undergoing elective Caesarean section. It has a double aperture design that facilitates the introduction of an orogastric tube to aspirate gastric contents.

The primary study hypothesis is the first attempt insertion success rate of SLMA use in urgent Caesarean section.

Conditions

  • Airway Morbidity

Interventions

DEVICE

Supreme Laryngeal Mask Airway

Supreme Laryngeal Mask Airway. Preoxygenation, rapid sequence induction and cricoid pressure. Induction of general anaesthesia.

Sponsors & Collaborators

  • KK Women's and Children's Hospital

    collaborator OTHER_GOV

  • QuanZhou Women and Children's Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-12-31
Completion
2015-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02026882 on ClinicalTrials.gov